PRESS RELEASE published on 07/22/2024 at 14:00, 8 months 17 days ago MIRA Pharmaceuticals Reveals Preclinical Success: Ketamir-2 Optimized for Brain Delivery, Avoiding Ketamine's Drug Resistance MIRA Pharmaceuticals reveals new promising preclinical data for Ketamir-2, a novel oral ketamine analog, indicating potential advantages for treating neurological and neuropsychiatric disorders Preclinical Study Neurological Disorders MIRA Pharmaceuticals Neuropsychiatric Disorders Ketamir-2
BRIEF published on 07/15/2024 at 13:05, 8 months 24 days ago Mira Pharmaceuticals annonce des résultats prometteurs pour MIRA-55 dans plusieurs tests précliniques par rapport au THC Médicaments Etudes Précliniques MIRA-55 Traitement De L'anxiété Comparaison Du THC
BRIEF published on 07/15/2024 at 13:05, 8 months 24 days ago Mira Pharmaceuticals Announces Promising Results for MIRA-55 in Multiple Preclinical Tests Compared to THC Pharmaceuticals Preclinical Studies MIRA-55 Anxiety Treatment THC Comparison
PRESS RELEASE published on 07/15/2024 at 13:00, 8 months 24 days ago Mira Pharmaceuticals Announces Promising Results for MIRA-55 in Multiple Preclinical Tests Compared to THC MIRA Pharmaceuticals, Inc. confirms promising findings on new oral pharmaceutical marijuana analog, MIRA-55, as a potential treatment for neurological and neuropsychiatric disorders. Comparison to THC shows enhanced efficacy and consistent anxiolytic effects Neurological Disorders Preclinical Studies MIRA-55 MIRA Pharmaceuticals Neuropsychiatric Disorders
Published on 04/09/2025 at 04:00, 1 hour 47 minutes ago QNX Now Powering WeRide's Next-Generation ADAS Platform
Published on 04/08/2025 at 22:47, 7 hours ago MicroVision Announces Retail Investor Day in Redmond, WA on May 20, 2025
Published on 04/08/2025 at 22:30, 7 hours 17 minutes ago Forte Group Announces Strategic Initiatives to Strengthen Financial Position
Published on 04/08/2025 at 22:10, 7 hours 37 minutes ago Gladstone Commercial Corporation Announces Monthly Cash Distributions for April, May and June 2025 and Earnings Release and Conference Call Dates for its First Quarter Ended March 31, 2025
Published on 04/08/2025 at 22:10, 7 hours 37 minutes ago Gladstone Land Announces Monthly Cash Distributions for April, May and June 2025 and Earnings Release and Conference Call Dates for the First Quarter Ended March 31, 2025
Published on 04/08/2025 at 23:45, 6 hours 2 minutes ago Redcare successfully executes placement of new convertible bonds and buys back part of the outstanding convertible bonds.
Published on 04/08/2025 at 23:21, 6 hours 26 minutes ago EQS-Adhoc: Redcare Pharmacy N.V. successfully places EUR 300 million convertible bonds and repurchases part of its outstanding EUR 225 million 0.00% convertible bonds due 2028
Published on 04/08/2025 at 22:58, 6 hours 49 minutes ago EQS-Adhoc: Semperit AG Holding: US tariff policy and lower global order activity lead to adjustment of EBITDA guidance for 2025 – Guidance 2026 suspended due to current high uncertainties
Published on 04/08/2025 at 18:52, 10 hours 55 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 04/08/2025 at 19:24, 10 hours 23 minutes ago Thales makes available its Universal Registration Document 2024
Published on 04/08/2025 at 19:24, 10 hours 23 minutes ago Thales met à disposition son Document d’Enregistrement Universel 2024
Published on 04/08/2025 at 18:46, 11 hours 1 minute ago Availability of the preparatory documents for the combined General Meeting of 29 April 2025
Published on 04/08/2025 at 18:46, 11 hours 1 minute ago Communiqué de mise à disposition des documents préparatoires à l’Assemblée Générale Mixte du 29 avril 2025
Published on 04/08/2025 at 17:57, 11 hours 50 minutes ago Déclaration des transactions sur actions propres réalisées du 31/03/2025 au 03/04/2025